Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 3 von 1577
The Journal of nutrition, health & aging, 2016-05, Vol.20 (5), p.496-502
2016

Details

Autor(en) / Beteiligte
Titel
Sarcopenia as a predictor of future cognitive impairment in older adults
Ist Teil von
  • The Journal of nutrition, health & aging, 2016-05, Vol.20 (5), p.496-502
Ort / Verlag
Paris: Springer Paris
Erscheinungsjahr
2016
Link zum Volltext
Quelle
SpringerNature Journals
Beschreibungen/Notizen
  • Objectives We investigated the association between the indices of sarcopenia and future risk of cognitive impairment in older adults. Design Community-based prospective cohort study. Setting Community. Participants A total of 297 participants aged ≥65 years without cognitive impairment at baseline (mean age, 71.9 ± 6.6 years; men:women, 158:139) and who underwent cognitive evaluation at the 5-year follow-up. Measurements Sarcopenia parameters including appendicular lean mass (ALM), handgrip strength, and the Short Physical Performance Battery (SPPB) score at baseline were compared according to the later progression of mild cognitive impairment (MCI) and/or dementia. The operational criteria suggested by the Foundation for the National Institutes of Health Sarcopenia Project were used. We performed multivariate logistic regression analysis to identify the independent indicators of the progression of cognitive impairment. Results Among the 297 participants, 242 (81.5%) remained cognitively normal (nonprogression group), whereas 55 (18.5%) showed progression of cognitive impairment (50 subjects (16.8%) to MCI and 5 subjects (1.7%) to dementia) (progression group). Compared with the nonprogression group, subjects in the progression group were older, had a lower educational level, and had lower physical function as assessed by the SPPB; a higher percentage were depressed. Other baseline markers of sarcopenia, including the ALM-to-body mass index ratio and handgrip strength did not differ significantly between the groups. The association between a low SPPB score (<9) and progression of cognitive impairment was maintained after adjustment for conventional risk factors for cognitive impairment (hazard ratio 2.222, 95% confidence interval 1.047–4.716, P = 0.038). Conclusion Decreased physical performance, as assessed by the SPPB, but not other markers of sarcopenia, was independently associated with the risk of later cognitive impairment in older adults.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX